Literature DB >> 7730495

Degenerative changes in myometrium simulating diffuse leiomyomatosis after treatment with gonadotrophin releasing hormone analogue.

M Jeffers1, C Cowan, C B Lunan.   

Abstract

Degenerative changes are encountered relatively frequently in uterine leiomyomas. Morphologic changes within leiomyomas, particularly necrosis and alterations in cellularity, have been described following treatment with gonadotrophin releasing hormone analogue, but the effects of this form of treatment on the morphology of the normal myometrium are less well documented. A case is reported of a 42 year old woman with a history of menorrhagia in whom a combination of degenerative and iatrogenic changes resulted in a histological appearance resembling diffuse leiomyomatosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7730495      PMCID: PMC502483          DOI: 10.1136/jcp.48.3.278

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  5 in total

1.  Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist.

Authors:  A J Friedman; R L Barbieri; B R Benacerraf; I Schiff
Journal:  Fertil Steril       Date:  1987-10       Impact factor: 7.329

2.  Vaginal hemorrhage associated with degenerating submucous leiomyomata during leuprolide acetate treatment.

Authors:  A J Friedman
Journal:  Fertil Steril       Date:  1989-07       Impact factor: 7.329

3.  Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate.

Authors:  M S Rein; A J Friedman; J M Stuart; D T MacLaughlin
Journal:  Fertil Steril       Date:  1990-06       Impact factor: 7.329

4.  Histopathological changes in leiomyomata treated with leuprolide acetate.

Authors:  N B Upadhyaya; M C Doody; P B Googe
Journal:  Fertil Steril       Date:  1990-11       Impact factor: 7.329

5.  The histopathology of uterine leiomyomas following treatment with gonadotropin-releasing hormone analogues.

Authors:  T J Colgan; S Pendergast; M LeBlanc
Journal:  Hum Pathol       Date:  1993-10       Impact factor: 3.466

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.